Claim OwnershipNeurology® Delayed Recall Podcast
Subscribed: 144Played: 1,305
Subscribe
Description
An archive of content from the Neurology® Podcast. Neurology® is the official journal of the American Academy of Neurology.
54 Episodes
Reverse
Dr. Luca Bartolini discusses autoimmune encephalitis and the role of antibody testing based on a Practice Current survey run between November 2017 and May 2018.
This month’s Delayed Recall highlights episodes on autoimmune neurology. Dr. David Lapides and Dr. Maarten Titulaer start the show discussing the long-term neuropsychological outcome following pediatric anti-nmdar encephalitis, which first aired on May 29th, 2018. The next segment, from January 15th, has Dr. Lapides and Dr. Balu focusing on a score that predicts one year functional status in anti-NMDA receptor encephalitis patients. Following this segment is one from October 23rd and finds Dr. Stacey Clardy talking to Dr. Andrew McKeon about his paper on paraneoplastic neuronal intermediate filament autoimmunity. This episode concludes with an interview on a Neurology: Neuroimmunology & Neuroinflammation paper on IgLON5 autoimmunity between Dr. Stacey Clardy and Dr. Andrew McKeon from March 27th, 2018.
This month’s Delayed Recall highlights episodes on drug pricing scandals and controversies. Dr. Ted Burns and Christopher Rowland of the Washington Post start the show discussing the investigation into a generic drug “cartel,” which first aired on January 1, 2019. The next segment, from January 22nd, has Dr. Burns and Casey Ross focusing on price hikes of prescription drugs. Following this segment is a two-part interview from January 8th and 15th and finds Dr. Gordon Smith talking to Dr. Steve Pearson about the Institute for Clinical and Economic Review and drug pricing.
This month’s Delayed Recall episode includes interviews on drug pricing. The episode starts with Dr. Jason Crowell’s interview with Dr. Gordon Smith from September 26, 2017 on orphan drug pricing. Following this clip, we have the full-length interview from the December 5, 2017 episode where Dr. Ted Burns speaks with Dr. John Mytinger on the drug Achtar for infantile ataxia. Next, in an interview from the July 4, 2017 podcast, Dr. Stacey Clardy focuses her interview with Dr. Dennis Bourdette on new immunotherapies. In the fourth and final interview, Dr. Ted Burns and reporter Ike Swetlitz discuss drug pricing practices and the different players in determining drug prices, which first aired in the May 1, 2018 episode of the podcast.
For the September 2018 Delayed Recall episode, we are featuring recordings of in-person interviews that took place at the April 2018 AAN Annual Meeting. All interviewees were plenary speakers who gave talks throughout Annual Meeting week. These recordings originally appeared as “What’s Trending” segments in July 2018 (July 17, 24, and 31, respectively). In the first interview, we will hear Dr. Alberto Espay speak with Dr. Jeff Lichtman about connectomics. Next, Dr. Stacey Clardy interviews Dr. Michael Wilson about his talk on next-generation sequencing and diagnosing meningitis and encephalitis. Last, Dr. Alberto Espay discusses the matter of who should be the primary caregivers for functional disorder patients with Dr. Andrea Leigh Haller and Dr. David Perez.
This month’s Delayed Recall features the Lesson of the Week series on functional disorders with Dr. David Lapides interviewing Dr. Jon Stone. The first interview provides an overview of functional disorders; next is a discussion of diagnostic approaches. The third segment highlights how to deliver a functional disorder diagnosis to a patient, and the final interview discusses treatment management. All these interviews were originally published in June and July 2018.
This month’s Delayed Recall episode consists of the Migraine Lesson of the Week series posted each week in January 2018. The episode starts with Dr. Teshamae Monteith’s interview with Dr. Stephen Silberstein (January 9, 2018) about updates in chronic migraine risk factors and management, followed by her interview with Dr. Jelena Pavlovic (January 16, 2018) on the interplay between migraine and hormones. Next, Dr. Monteith focuses her interview with Dr. Stuart Tepper on neuromodulation (January 23, 2018). In the fourth and final interview, Dr. Monteith and Dr. Benjamin Friedman discuss emergency management of migraine (January 30, 2018).
The Delayed Recall episode for June takes a look at recent guidelines and developments in the field of multiple sclerosis treatment. In the first interview, Dr. Stacey Clardy and Dr. Alexander Rae-Grant discuss recent practice guidelines for multiple sclerosis, and talk about Dr. Rae-Grant’s paper regarding these guidelines. This interview first aired on April 24, 2018. The second interview, from the May 15, 2018 episode, features Dr. Clardy speaking with Dr. Riley Bove about her recent paper on rituximab treatment during pregnancy. Next, hear Dr. Clardy speak with Dr. Raed Alroughani about relapse occurrence of MS during pregnancy, in an interview that appeared in the March 6, 2018 episode. In the conclusion to this month’s episode, Dr. Mark Keegan and Dr. Gavin Giovannoni discuss the topic of alemtuzumab treatment for multiple sclerosis patients. This interview first appeared on April 18, 2017.
This month’s Delayed Recall episode includes interviews on topics that were highlighted in the Neurology Today "Best Advances of 2017" editorial. The episode starts with Dr. Andy Southerland's interview with Dr. Joseph Safdieh (April 10, 2018) that features a few editor's pick from the Best Advances in neurology in 2017. Following this clip, we have the full-length interview from the February 28, 2017 episode where Dr. Ted Burns speaks with Dr. Richard Finkel about nusinersen and spinal muscular atrophy. Next, in an interview from the February 13, 2018 podcast, Dr. Tesha Monteith focuses her interview with Dr. Peter Goadsby on CGRP treatments and migraine. In the third and final interview, Dr. Nicole Chiota-McCollum and Dr. Greg Albers regarding the DEFUSE trial results, which first aired in the April 17, 2018 episode of the podcast.
This special Delayed Recall episode is the third installment of our new Practice Current segment. In this episode, Dr. Luca Bartolini speaks with epilepsy experts Dr. Cynthia Harden and Dr. Torbjörn Tomson. They discuss the results of a recent Practice Current (a section of Neurology® Clinical Practice) survey regarding epilepsy treatment and management during pregnancy, and share their thoughts regarding best practices. This is the first appearance of this interview in the podcast.
This month’s Delayed Recall episode includes three recent interviews on the topic of cognitive impairment. In the first interview, from the January 16, 2018 episode, Dr. Jeff Burns speaks with Dr. Ronald Petersen about the recent AAN practice guideline paper on mild cognitive impairment. Next, in and interview from the January 2, 2018 podcast, Dr. Ted Burns and Dr. Damian Garde discuss recent Alzheimer disease trials; and in the third and final interview, Dr. Matthew Elliot talks with Dr. Hugh Markus about his paper “Multimodal MRI markers and dementia risk in cerebral small vessel disease.” This interview first aired in the October 31, 2017 episode of the podcast.
This month's Delayed Recall episode comprises an update regarding recent developments in the field of stroke, and includes four interviews from 2017 that focused on this topic. The first interview aired in the September 12 episode, and features a discussion between Dr. Kevin Barrett and Dr. Tudor Jovin regarding the recent DAWN trial. Next, Dr. David Ackerman and Dr. Gene Latorre take a look at the stroke rehabilitation quality measurement set update that was published in Neurology® in October of 2017. This interview appeared as part of the Oct. 10 podcast episode. The third interview of this month's Delayed Recall was featured in the October 24 episode; in it, Dr. Justin Sattin talks about the use of Tenecteplase for acute ischemic stroke with Dr. Nicola Logallo. The final interview, by Dr. Nichole Chiota with Dr. Steven Messe, covers the recent PFO Update. This segment was featured in the November 7 episode.
Delayed Recall - Patient Perspectives, Part II (January 2018)
This month’s Delayed Recall episode features Dr. Stacey Clardy’s Lesson of the Week interviews on the topic of immunotherapy, which originally aired in July 2017. In the first interview, Dr. Clardy speaks with Dr. Dennis Bourdette about new immunotherapies in neurology. This interview first appeared in the July 4 episode. In the interview from July 11, Dr. Clardy continues the discussion about new immunotherapies with Dr. Jeffrey Cohen. The third interview, from the July 18 episode, features Dr. Clardy speaking with Dr. Emmanuelle Waubant about immunotherapy as it applies to multiple sclerosis patients. To conclude this episode, we offer Dr. Clardy’s interview with Dr. Anne Cross, in which they talk about immunosuppressants in Neurology; this interview was part of the July 25 episode.
This special Delayed Recall episode is the second installment of our new Practice Current segment. In this episode, Dr. Luca Bartolini speaks with neuromyelitis optica (NMO) experts Dr. Tarso Adoni and Dr. Michael Levy. They discuss the results of a recent Practice Current (a section of Neurology® Clinical Practice) survey regarding NMO treatment, and share their thoughts on best practices. This is the first appearance of this interview in the podcast.
The first interview in this month’s Delayed Recall episode is from March 17, 2015; in this interview, Dr. Howard Goodkin and Dr. Robert Stern discuss the effect that age of first exposure to football has on later-life cognitive impairment in former NFL players. The second interview, from August 29, 2017, is a discussion between Dr. Jason Crowell and Dr. Jesse Mez about a July 2017 JAMA paper on occurrence of CTE in American football players. In the third interview, Dr. Christopher Giza speaks with Dr. John Hart about Dr. Hart’s paper regarding depressive symptoms and white matter dysfunction in retired NFL players with concussion history. This interview originally appeared in the July 1, 2013 episode. The fourth and final interview is a discussion between Dr. Ted Burns and former NFL player Ben Utecht, regarding Mr. Utecht’s Sept 23, 2014 editorial, “Concussed.”
This month’s special Delayed Recall episode takes a look back at the 2017 Annual Meeting, which took place in April 2017 in Boston, MA. In the four interviews featured in this episode, Dr. Andy Southerland and Dr. Alberto Espay speak with four of the plenary speakers who gave talks on hot topics during Annual Meeting. In the first interview, Dr. Southerland talks with Dr. Jonathan Kipnis about his talk regarding the role of CNS-draining lymphatics in neurological diseases. In the second, Dr. Espay talks about how early we can diagnose Alzheimer’s disease with Dr. Ronald Petersen. Next, Dr. Southerland discusses the use of oral anticoagulation after intracerebral hemorrhage with Dr. Alessandro Biffi. Last, Dr. George Perry is interviewed by Dr. Espay regarding his talk on amyloid removal and cognition in Alzheimer’s disease.
1In this month's Delayed Recall episode, we are featuring four interviews by Dr. Kait Nevel on the topic of neuro-oncology. In the first interview, Dr. Nevel speaks with Dr. Jennie Taylor about neuro-oncology and seizures. In the second, she discusses intracranial pressure with Dr. Mariza Daras. These interviews originally appeared in the March 7 and March 14 episodes, respectively. Next, Dr. Nevel and Dr. Lisa DeAngelis talk about metastatic diseases in neurology, in a segment that appeared in the March 21 episode. Last, Dr. Nevel discusses gliomas with Dr. David Schiff in an interview from March 28.
Practice Current: Antiepileptic Drug DiscontinuationIn this special Delayed Recall episode, Dr. Luca Bartolini speaks with epilepsy experts Dr. Greg Cascino, Dr. Ali Asadi-Pooya, and Dr. Ley Sander. They discuss the results of a recent Practice Current (a section of Neurology® Clinical Practice) survey regarding antiepileptic drug discontinuation, and share their thoughts on best practices with regard to the case studies presented to the survey respondents. This is the first appearance of this interview in the podcast.
We are producing and releasing 4 special podcast interviews this month dedicated to responsible opioid prescribing. We are doing this largely as a response to the ongoing opioid epidemic, in the U.S. and also around the world. Also, many state boards in the U.S. are now requiring a few hours of CME for responsible opioid prescribing, and these podcasts would likely be eligible for a total 2 hour of category 1 CME-but you may want to check with your U.S. state board mandates on that to be sure. Regardless of CME, we felt these topics deserved covering now so that's what's we at the Podcast are doing. All four will be released this month.
Comments
Download from Google Play
Download from App Store
United States